Goldman Sachs’s Tenax Therapeutics TENX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.19M Buy
627,023
+352,077
+128% +$2.65M ﹤0.01% 5103
2026
Q2
$4M Buy
274,946
+243,092
+763% +$3.11M ﹤0.01% 4084
2026
Q1
$509K Buy
31,854
+9,445
+42% +$128K ﹤0.01% 5583
2025
Q4
$273K Buy
+22,409
New +$195K ﹤0.01% 5909
2020
Q3
– Sell
-14
Closed -$20K – 5535
2020
Q2
$20K Buy
+14
New +$20.6K ﹤0.01% 5127
2016
Q2
– Sell
-1
Closed -$54K – 7251
2016
Q1
$54K Hold
1
– – ﹤0.01% 6387
2015
Q4
$84K Hold
1
– – ﹤0.01% 6276
2015
Q3
$64K Hold
1
– – ﹤0.01% 6688
2015
Q2
$79K Hold
1
– – ﹤0.01% 6719
2015
Q1
$73K Hold
1
– – ﹤0.01% 6566
2014
Q4
$136K Sell
1
-1
-50% -$121K ﹤0.01% 6422
2014
Q3
$190K Buy
+2
New +$257K ﹤0.01% 6210

Other funds holding TENX

Goldman Sachs's TENX Position: Q3 2026 in Review

Goldman Sachs increased its Tenax Therapeutics (TENX) stake by 128% in Q3 2026, buying an estimated $2.65M and bringing the position to 627,023 shares worth $1.19M. The position accounts for ﹤0.01% of the portfolio, ranked #5103.

Goldman Sachs first reported a position in TENX in Q3 2014 and has held it in 12 quarters since. The position peaked at $4M in Q2 2026. 106 funds tracked by Wall St. Rank hold TENX as of Q3 2026.

  • Goldman Sachs held 627,023 shares of Tenax Therapeutics worth $1.19M as of Q3 2026.
  • Goldman Sachs bought 352,077 Tenax Therapeutics shares in Q3 2026, an estimated $2.65M.
  • Tenax Therapeutics made up ﹤0.01% of Goldman Sachs's portfolio in Q3 2026, its #5103 holding.
  • Goldman Sachs first reported a position in Tenax Therapeutics in Q3 2014 and has held it in 12 quarters since.
  • Goldman Sachs's Tenax Therapeutics position peaked at $4M in Q2 2026.
  • 106 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q3 2026.

Based on Goldman Sachs's 13F filing for Q3 2026, filed 16 Nov 2026.